Skip to main content
AmigoFish

Stifel's Head of Therapeutics Research Paul Matteis shares his take on biotech and discusses companies he covers that have been in the news

From BiotechTV - News · · 12 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

He discusses Biogen, Alnylam, Xenon, and Compass Pathways

Back to BiotechTV - News · Report a problem